Clinical Trial Results
Clinical Trial
Results
Research Sponsor: AstraZeneca
Drugs Studied: Pramlintide
National Clinical Trial #: NCT02500979
Protocol #: D5570C00002
Study Date: August 2015 to August 2016
Short Study Title: A study to learn if pramlintide helps control
blood sugar levels in participants who have
type 1 diabetes and take insulin.
Thank you!
As a clinical study participant, you belong to a large community of
participants around the world. You help researchers answer important
health questions and discover new medical treatments.
Thank you for taking part in this clinical study for a drug called
pramlintide. This drug has been approved to treat type 1 diabetes.
You and all of the other participants helped researchers learn how
pramlintide affects blood sugar levels and if pramlintide is safe to
take when given with insulin in a pump.
AstraZeneca, the sponsor of this study, thanks you for your help
and thinks it is important for you to know the results of your study.
An independent non-profit organization called CISCRP prepared
this summary of the study results for you with the help of a medical
writing organization. We hope it helps you understand and feel proud
of your important role in medical research. If you have questions
about the results, please speak with the study doctors or staff at your
study site.
1